Literature DB >> 10824389

Patients' perceptions of a telemedicine specialty clinic.

F Mair1, P Whitten, C May, G C Doolittle.   

Abstract

We studied patients' perceptions of telemedicine (interactive video) as a means of delivering specialist oncology/haematology care. Semistructured telephone interviews were performed with 22 patients attending a tele-oncology/haematology clinic in Kansas. Interviews were audio-taped and thematic content analysis of the transcripts was done. The response rate was 96%. All participants expressed satisfaction with their tele-consultations. For 50% of respondents, satisfaction with the tele-oncology/haematology clinic was qualified by two factors: participants also saw the specialist in person on occasions and the clinic was perceived as providing mainly a 'monitoring' function. In addition, 9 of the 22 patients expressed concern about the role of the nurse as a proxy for the doctor in performing certain parts of the physical examination. Overall, participants valued improved access to specialist services but had clear views as to the limitations of such a service. As the use of telecommunications technology grows, patient perspectives merit greater attention.

Entities:  

Mesh:

Year:  2000        PMID: 10824389     DOI: 10.1258/1357633001933925

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  16 in total

1.  Providing Access to Oncology Care for Rural Patients via Telemedicine.

Authors:  Gary C Doolittle; Ashley O Spaulding
Journal:  J Oncol Pract       Date:  2006-09       Impact factor: 3.840

2.  Patient and family experiences with accessing telephone cancer treatment symptom support: a descriptive study.

Authors:  Dawn Stacey; Esther Green; Barbara Ballantyne; Myriam Skrutkowski; Angela Whynot; Lucie Tardif; Joy Tarasuk; Meg Carley
Journal:  Support Care Cancer       Date:  2015-08-15       Impact factor: 3.603

Review 3.  The Role of Telemedicine in Providing Thoracic Oncology Care to Remote Areas of British Columbia.

Authors:  Michael F Humer; Barbara G Campling
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

4.  Acceptability of telemedicine and other cancer genetic counseling models of service delivery in geographically remote settings.

Authors:  Eileen McDonald; Amanda Lamb; Barbara Grillo; Lee Lucas; Susan Miesfeldt
Journal:  J Genet Couns       Date:  2013-09-08       Impact factor: 2.537

5.  How effective is video consultation in clinical oncology? A systematic review.

Authors:  C Kitamura; L Zurawel-Balaura; R K S Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

6.  Women's experience of telehealth cancer genetic counseling.

Authors:  Elvira M Zilliacus; Bettina Meiser; Elizabeth A Lobb; Judy Kirk; Linda Warwick; Katherine Tucker
Journal:  J Genet Couns       Date:  2010-04-22       Impact factor: 2.537

7.  The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience.

Authors:  V Formica; E Fossile; R Pellegrino; M Fatale; M Mari; M Rabuffetti; F R Benedetto; G Visconti; E Bollero; M Roselli
Journal:  Support Care Cancer       Date:  2008-12-17       Impact factor: 3.603

8.  Technology-based patient consultations: research findings from haematology patients in regional, rural and remote queensland.

Authors:  Pam McGrath
Journal:  Patient       Date:  2015-04       Impact factor: 3.883

9.  The impact of medical teleconsultations on general practitioner-patient communication during COVID- 19: A case study from Poland.

Authors:  Magdalena Kludacz-Alessandri; Liliana Hawrysz; Piotr Korneta; Grażyna Gierszewska; Wioletta Pomaranik; Renata Walczak
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

10.  A qualitative study on patients' and their support persons' preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation.

Authors:  Anne Herrmann; Ernst Holler; Matthias Edinger; Sascha Eickmann; Daniel Wolff
Journal:  BMC Health Serv Res       Date:  2021-06-30       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.